Skip to main content

Table 2 Participants’ characteristics and baseline values for physical activity covariates

From: Effect of a 1-year intervention comprising brief counselling sessions and low-dose physical activity recommendations in Japanese adults, and retention of the effect at 2 years: a randomized trial

 

Active (N = 230)

Control (N = 161)

PA intervention (N = 183)

Participant characteristics

Women/men

156/74

114/47

128/55

Age (year)

50 ± 9

48 ± 10

48 ± 9

BMI (kg/m2)

22.2 ± 2.6

22.2 ± 2.6

22.6 ± 3.2

Do/do not achieve 3.3 MET-h/d

230/0

39/122

45/138

Do/do not achieve 10,000 steps/d

230/0

21/140

23/160

Nutrition parameters

Total energy intakes (kcal)

1854 ± 511

1787 ± 488

1775 ± 449

Protein intakes (g/1000 kcal)

38 ± 7

37 ± 6

37 ± 6

Carbohydrate intakes (g/1000 kcal)

133 ± 17

138 ± 17

136 ± 19

Fat intakes (g/1000 kcal)

28 ± 5

28 ± 6

29 ± 6

Body composition

   

Weight (kg)

58 ± 10

58 ± 9

59 ± 10

Waist circumference (cm)

79 ± 9

80 ± 8

82 ± 9

Physical fitness parameters

Trunk flexibility (cm)

41 ± 8 (N = 229)

40 ± 11

40 ± 10 (N = 182)

Vertical jump (cm)

35 ± 10 (N = 224)

35 ± 10 (N = 159)

34 ± 10 (N = 177)

Peak oxygen consumption (mL/kg/min)

33 ± 7 (N = 222)*

30 ± 6 (N = 155)

30 ± 6 (N = 177)

Cardiovascular parameters

Heart-rate (bpm)

61 ± 11*

65 ± 10

65 ± 13

Mean arterial pressure (mmHg)

90 ± 12

88 ± 11

89 ± 12

baPWV (cm/s)

1228 ± 144

1229 ± 157

1236 ± 185

Blood markers

Glucose (mg/dL)

90 ± 8

88 ± 9

90 ± 8

HbA1c (%)

5.3 ± 0.3

5.3 ± 0.3

5.3 ± 0.3

TG (mg/dL)

84 ± 45

90 ± 60

90 ± 49

Total cholesterol (mg/dL)

211 ± 33

207 ± 36

208 ± 33

  1. Mean ± standard deviation. N = 230, 161, and 183 for the active, control, and low-dose PA intervention groups, respectively, except when otherwise noted
  2. baPWV, brachial-ankle pulse wave velocity; BMI, body mass index; HbA1c, glycosylated hemoglobin; LPA, light physical activity; MPA, moderate physical activity; MVPA, moderate-to-vigorous physical activity; PA, physical activity; TG, triglyceride
  3. *Different from the two other groups
  4. Different from the “active” group